tradmap

DTIL PRECISION BIOSCIENCES INC

$7.36 -1.47%

Updated

Healthcare · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC (DTIL) is a healthcare company in the Biological Products, (No Diagnostic Substances) industry, with a market capitalization of $203 million. Shares last traded at $7.36, 23.4% below their 52-week high. Over the past year the stock is up 47.5%. Net profit margin is -117.0%, below the peer median of 5.3%. Revenue declined 50.1% year over year.

Market Cap
$203M
Shares Out
27.6M
EPS (TTM)
$-13.24
P/E Ratio
P/S Ratio
4.51
P/B Ratio
4.49
Dividend / Share
Dividend Yield
52-Week High
$9.61
52-Week Low
$3.49
Volume
6,933
Avg Vol (3m)
26,639.73

Performance

1W
-12.28%
1M
-1.60%
3M
+15.00%
6M
+62.47%
YTD
+79.51%
1Y
+47.49%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. DTIL split history →

Technicals

RSI (14)
40.56
SMA (50)
$7.85
SMA (200)
$6.14
Price vs SMA50
-6.20%
Price vs SMA200
+19.83%
ATR (14)
$0.52

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$45M
Net Income
$-53M
Gross Margin
Operating Margin
-80.8%
Net Margin
-117.0%
Return on Equity
-116.4%
Return on Assets
-41.9%
Current Ratio
12.82
Debt / Equity
0.49
Revenue Growth (YoY)
-50.1%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-2.02 2026-08-06
Q1 2026 $-0.75 2026-05-05
FY 2025 $-3.56 2026-03-12
Q3 2025 $-6.14 2025-11-03
Q2 2026 $-4.33 2026-08-06
Q1 2026 $-2.21 2026-05-05

Full earnings history →

Biological Products, (No Diagnostic Substances) peers

DTIL vs 14 industry peers (Biological Products, (No Diagnostic Substances)), by market cap. Updated

P/S vs peers
4.51 / 19.49 med
-77% discount
Net margin vs peers
-117.0% / 5.3% med
below median
1–14 of 14
AMGNAmgen$240.1B27.476.3023.0%+0.31%
GILDGilead Sciences$187.5B-57.876.16-10.6%+1.09%
MRNAModerna$58.8B-18.68-1.94%
RVMDRevolution Medicines, Inc.$45.2B-25.55+0.76%
BIIBBiogen$33.1B24.163.3413.8%+0.78%
NBIXNeurocrine Biosciences Inc$16.1B22.814.7720.9%+0.33%
EXELExelixis, Inc.$14.7B17.036.0235.3%+1.00%
HALOHalozyme Therapeutics, Inc.$12.6B30.397.5524.9%+1.01%
TECHBio-Techne$11.4B62.489.3515.0%+0.21%
KRYSKrystal Biotech, Inc.$11.0B45.5224.9554.8%+0.58%
APGEApogee Therapeutics, Inc.$10.2B-34.57+0.04%
KYMRKymera Therapeutics, Inc.$9.7B-32.51-1.24%
RGENRepligen Corp$9.6B230.5312.205.3%-1.87%
PCVXVaxcyte, Inc.$9.1B-8.56-0.62%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.